ArticleJournal of gastrointestinal oncology2026

Neoadjuvant adebrelimab combined with triplet chemotherapy for locally advanced resectable adenocarcinoma of esophagogastric junction: a prospective, single-arm, phase II feasibility and safety study.

Jinqiang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.